VITAF Stock Overview
Operates in the sector of pharmaceutical products. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Pharmaceutical Center SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €1.18 |
52 Week High | €1.18 |
52 Week Low | €1.18 |
Beta | 0 |
11 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -1.67% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
VITAF | CY Healthcare | CY Market | |
---|---|---|---|
7D | n/a | -2.8% | 0.8% |
1Y | n/a | -3.5% | 54.1% |
Return vs Industry: Insufficient data to determine how VITAF performed against the CY Healthcare industry.
Return vs Market: Insufficient data to determine how VITAF performed against the CY Market.
Price Volatility
VITAF volatility | |
---|---|
VITAF Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 5.2% |
Market Average Movement | 4.6% |
10% most volatile stocks in CY Market | 7.7% |
10% least volatile stocks in CY Market | 2.3% |
Stable Share Price: VITAF's share price has been volatile over the past 3 months compared to the CY market.
Volatility Over Time: Insufficient data to determine VITAF's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | n/a | n/a |
Pharmaceutical Center SA operates in the sector of pharmaceutical products. The company is based in Pylaia, Greece.
Pharmaceutical Center SA Fundamentals Summary
VITAF fundamental statistics | |
---|---|
Market cap | €23.00m |
Earnings (TTM) | €0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs VITAF overvalued?
See Fair Value and valuation analysisEarnings & Revenue
VITAF income statement (TTM) | |
---|---|
Revenue | €0 |
Cost of Revenue | €0 |
Gross Profit | €0 |
Other Expenses | €0 |
Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did VITAF perform over the long term?
See historical performance and comparison